Destiny Wealth Partners’s Genmab GMAB Stock Holding History

Destiny Wealth Partners’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-110	Closed	-$2.95K	–	525
2026 Q1	$2.95K	Buy	+110	New	+$3.3K	﹤0.01%	1032

Other funds holding GMAB

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Destiny Wealth Partners's GMAB Position: Q2 2026 in Review

Destiny Wealth Partners sold out of Genmab (GMAB) in Q2 2026, closing a stake of 110 shares — an estimated $2.95K sold.

Destiny Wealth Partners first reported a position in GMAB in Q1 2026 and held it in 1 quarter. The position peaked at $2.95K in Q1 2026. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

Destiny Wealth Partners reported no remaining Genmab position as of Q2 2026 after selling out during the quarter.
Destiny Wealth Partners sold 110 Genmab shares in Q2 2026, an estimated $2.95K.
Destiny Wealth Partners first reported a position in Genmab in Q1 2026 and held it in 1 quarter.
Destiny Wealth Partners's Genmab position peaked at $2.95K in Q1 2026.
290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Destiny Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.